Indication for plasma exchange for systemic necrotizing vasculidities

Transfusion and Apheresis Science

Volumn 36, Issue 2, 2007, Pages 179-185

  Guillevin, Loïc ^a   Pagnoux, Christian ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CYTOPLASM; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG HEMORRHAGE; NECROTIZING ARTERITIS; PLASMAPHERESIS; TREATMENT OUTCOME;

CRYOGLOBULINEMIA; HEPATITIS C; HIV INFECTIONS; HUMANS; PLASMA EXCHANGE; POLYARTERITIS NODOSA; RECURRENCE; SURVIVAL ANALYSIS; VASCULITIS;

EID: 34248171086     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.01.006     Document Type: Article

References (22)

1. Trépo C. Hépatite virale B et périartérite noueuse. Nouv Presse Méd 1 (1972) 1879-1881
2. Agnello V., Chung R.T., and Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 (1992) 1490-1495
3. Ferri C., Greco F., Longombardo G., Palla P., Marzo E., and Moretti A. Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exp Rheumatol 9 (1991) 95-96
4. Corman L.C., and Dolson D.J. Polyarteritis nodosa and parvovirus B19 infection. Lancet 339 (1992) 491
5. Guillevin L., Mahr A., Callard P., Godmer P., Pagnoux C., Leray E., et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84 (2005) 313-322
6. Prince A.M., and Trépo C. Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lancet 1 (1971) 1309-1312
7. Pagnoux C., Mahr A., Cohen P., and Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculidities: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 84 (2005) 115-128
8. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculidities. Proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
9. Calabrese L.H. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am 17 (1991) 131-147
10. Gisselbrecht M., Cohen P., Lortholary O., Jarrousse B., Gayraud M., Lecompte I., et al. Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Ann Méd Interne (Paris) 149 (1998) 398-405
11. McMahon B.J., Heyward W.L., Templin D.W., Clement D., and Lanier A.P. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 9 (1989) 97-101
12. Guillevin L., Lhote F., Léon A., Fauvelle F., Vivitski L., and Trépo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol 20 (1993) 289-298
13. Rieu V., Cohen P., André M., Mouthon L., Godmer P., Jarrousse B., et al. Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford) 41 (2002) 290-300
14. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116 (1992) 488-498
15. Adu D., Pall A., Luqmani R.A., Richards N.T., Howie A.J., Emery P., et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM 90 (1997) 401-409
16. Guillevin L., Cordier J., Lhote F., Cohen P., Jarrousse B., Royer I., et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 40 (1997) 2187-2198
17. Guillevin L., Fain O., Lhote F., Jarrousse B., Lê Thi Huong D., Bussel A., et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 35 (1992) 208-215
18. Guillevin L., Jarrousse B., Lok C., Lhote F., Jaïs J.P., Lê T.H.D., et al. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol 18 (1991) 567-574
19. Guillevin L., Lhote F., Cohen P., Jarrousse B., Lortholary O., Généreau T., et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum 38 (1995) 1638-1645
20. Jayne D, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomised trial of plasma exchange versus methylprednisolone for severe renal vasculitis, submitted for publication.
21. Mouthon L. Indications des immunoglobulines intra-veineuses. Presse Méd 3 (2006) 714-719
22. Keogh K.A., Ytterberg S.R., Fervenza F.C., Carlson K.A., Schroeder D.R., and Specks U. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173 (2006) 180-187